{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T04:07:12Z","timestamp":1791173232982,"version":"4.1.0"},"reference-count":38,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2011,12,16]],"date-time":"2011-12-16T00:00:00Z","timestamp":1323993600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0029061","type":"journal-article","created":{"date-parts":[[2011,12,16]],"date-time":"2011-12-16T21:59:17Z","timestamp":1324072757000},"page":"e29061","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":47,"title":["Comparison of Dysferlin Expression in Human Skeletal Muscle with That in Monocytes for the Diagnosis of Dysferlin Myopathy"],"prefix":"10.1371","volume":"6","author":[{"given":"Eduard","family":"Gallardo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noemi","family":"de Luna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Diaz-Manera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Rojas-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidia","family":"Gonzalez-Quereda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e0rbara","family":"Flix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"de Morr\u00e9e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silv\u00e8re","family":"van der Maarel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Illa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2011,12,16]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/1689","article-title":"A gene related to Caenorhabditis elegans spermatogenesis factor fer-1 is mutated in limb-girdle muscular dystrophy type 2B.","volume":"20","author":"R Bashir","year":"1998","journal-title":"Nat Genet"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/1682","article-title":"Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy.","volume":"20","author":"J Liu","year":"1998","journal-title":"Nat Genet"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1212\/01.wnl.0000256768.79353.60","article-title":"Symptomatic dysferlin gene mutation carriers: characterization of two cases.","volume":"68","author":"I Illa","year":"2007","journal-title":"Neurology"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/1531-8249(200101)49:1<130::AID-ANA22>3.0.CO;2-0","article-title":"Distal anterior compartment myopathy: a dysferlin mutation causing a new muscular dystrophy phenotype.","volume":"49","author":"I Illa","year":"2001","journal-title":"Ann Neurol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.nmd.2008.01.004","article-title":"Late onset in dysferlinopathy widens the clinical spectrum.","volume":"18","author":"L Klinge","year":"2008","journal-title":"Neuromuscul Disord"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1001\/archneur.64.8.1176","article-title":"Phenotypic study in 40 patients with dysferlin gene mutations: high frequency of atypical phenotypes.","volume":"64","author":"K Nguyen","year":"2007","journal-title":"Arch Neurol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2169\/internalmedicine.47.0519","article-title":"Asymptomatic sporadic dysferlinopathy presenting with elevation of serum creatine kinase. Typical distribution of muscle involvement shown by MRI but not by CT.","volume":"47","author":"S Okahashi","year":"2008","journal-title":"Intern Med"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"289","DOI":"10.4103\/0028-3886.43447","article-title":"Dysferlinopathies.","volume":"56","author":"JA Urtizberea","year":"2008","journal-title":"Neurol India"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1001\/archneur.62.8.1256","article-title":"Identification of a novel founder mutation in the DYSF gene causing clinical variability in the Spanish population.","volume":"62","author":"JJ Vilchez","year":"2005","journal-title":"Arch Neurol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.nmd.2008.09.015","article-title":"A new phenotype of dysferlinopathy with congenital onset.","volume":"19","author":"C Paradas","year":"2009","journal-title":"Neuromuscul Disord"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1212\/WNL.0b013e3181ea1564","article-title":"Redefining dysferlinopathy phenotypes based on clinical findings and muscle imaging studies.","volume":"75","author":"C Paradas","year":"2010","journal-title":"Neurology"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/ana.10080","article-title":"A novel, blood-based diagnostic assay for limb girdle muscular dystrophy 2B and Miyoshi myopathy.","volume":"51","author":"M Ho","year":"2002","journal-title":"Ann Neurol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.nmd.2009.08.004","article-title":"Immunolabelling and flow cytometry as new tools to explore dysferlinopathies.","volume":"20","author":"N Wein","year":"2010","journal-title":"Neuromuscul Disord"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.nmd.2007.08.009","article-title":"Limb-girdle muscular dystrophy: diagnostic evaluation, frequency and clues to pathogenesis.","volume":"18","author":"HP Lo","year":"2008","journal-title":"Neuromuscul Disord"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1002\/1531-8249(200012)48:6<902::AID-ANA11>3.0.CO;2-Z","article-title":"Intracellular accumulation and reduced sarcolemmal expression of dysferlin in limb\u2013girdle muscular dystrophies.","volume":"48","author":"F Piccolo","year":"2000","journal-title":"Ann Neurol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0022-510X(03)00041-8","article-title":"Protein and gene analyses of dysferlinopathy in a large group of Japanese muscular dystrophy patients.","volume":"211","author":"K Tagawa","year":"2003","journal-title":"J Neurol Sci"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s00401-002-0593-x","article-title":"Miyoshi myopathy patients with novel 5\u2032 splicing donor site mutations showed different dysferlin immunostaining at the sarcolemma.","volume":"104","author":"A Saito","year":"2002","journal-title":"Acta Neuropathol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/mus.21650","article-title":"Novel diagnostic features of dysferlinopathies.","volume":"42","author":"XQ Rosales","year":"2010","journal-title":"Muscle Nerve"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"50466","DOI":"10.1074\/jbc.M307247200","article-title":"Dysferlin interacts with annexins A1 and A2 and mediates sarcolemmal wound-healing.","volume":"278","author":"NJ Lennon","year":"2003","journal-title":"J Biol Chem"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1093\/hmg\/ddn081","article-title":"Calpain 3 is a modulator of the dysferlin protein complex in skeletal muscle.","volume":"17","author":"Y Huang","year":"2008","journal-title":"Hum Mol Genet"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/sj.ejhg.5201414","article-title":"Protein studies in dysferlinopathy patients using llama-derived antibody fragments selected by phage display.","volume":"13","author":"Y Huang","year":"2005","journal-title":"Eur J Hum Genet"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1093\/hmg\/10.17.1761","article-title":"The sarcolemmal proteins dysferlin and caveolin-3 interact in skeletal muscle.","volume":"10","author":"C Matsuda","year":"2001","journal-title":"Hum Mol Genet"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1096\/fj.06-6628com","article-title":"AHNAK, a novel component of the dysferlin protein complex, redistributes to the cytoplasm with dysferlin during skeletal muscle regeneration.","volume":"21","author":"Y Huang","year":"2007","journal-title":"Faseb J"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1093\/jnen\/64.4.334","article-title":"Dysferlin interacts with affixin (beta-parvin) at the sarcolemma.","volume":"64","author":"C Matsuda","year":"2005","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref25","first-page":"134","article-title":"Intracellular localization of dysferlin and its association with the dihydropyridine receptor.","volume":"24","author":"BN Ampong","year":"2005","journal-title":"Acta Myol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"15894","DOI":"10.1074\/jbc.M109.009589","article-title":"Membrane repair defects in muscular dystrophy are linked to altered interaction between MG53, caveolin-3, and dysferlin.","volume":"284","author":"C Cai","year":"2009","journal-title":"J Biol Chem"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"e10122","DOI":"10.1371\/journal.pone.0010122","article-title":"Dysferlin interacts with tubulin and microtubules in mouse skeletal muscle.","volume":"5","author":"BA Azakir","year":"2010","journal-title":"PLoS One"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0960-8966(00)00143-7","article-title":"Secondary reduction in calpain 3 expression in patients with limb girdle muscular dystrophy type 2B and Miyoshi myopathy (primary dysferlinopathies).","volume":"10","author":"LV Anderson","year":"2000","journal-title":"Neuromuscul Disord"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.nmd.2004.05.005","article-title":"Mutations in Czech LGMD2A patients revealed by analysis of calpain3 mRNA and their phenotypic outcome.","volume":"14","author":"T Chrobakova","year":"2004","journal-title":"Neuromuscul Disord"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/mus.20480","article-title":"Analysis of histopathologic and molecular pathologic findings in Czech LGMD2A patients.","volume":"33","author":"M Hermanova","year":"2006","journal-title":"Muscle Nerve"},{"key":"ref31","article-title":"Muscular dystrophy with marked Dysferlin deficiency is consistently caused by primary dysferlin gene mutations.","author":"M Cacciottolo","year":"2011","journal-title":"Eur J Hum Genet"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1212\/WNL.57.11.2136","article-title":"Inflammation in dysferlin myopathy: immunohistochemical characterization of 13 patients.","volume":"57","author":"E Gallardo","year":"2001","journal-title":"Neurology"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/ana.21309","article-title":"Dysferlin-deficient muscular dystrophy features amyloidosis.","volume":"63","author":"S Spuler","year":"2008","journal-title":"Ann Neurol"},{"key":"ref34","article-title":"Differential recognition of vascular and parenchymal beta amyloid deposition.","author":"KS Rutgers","year":"2009","journal-title":"Neurobiol Aging"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.nmd.2006.09.006","article-title":"Dysferlin expression in monocytes: a source of mRNA for mutation analysis.","volume":"17","author":"N De Luna","year":"2007","journal-title":"Neuromuscul Disord"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1093\/jnen\/63.10.1104","article-title":"In vivo and in vitro dysferlin expression in human muscle satellite cells.","volume":"63","author":"N De Luna","year":"2004","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/S0002-9440(10)65354-0","article-title":"Multiplex Western blotting system for the analysis of muscular dystrophy proteins.","volume":"154","author":"LV Anderson","year":"1999","journal-title":"Am J Pathol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.neulet.2005.08.026","article-title":"Variable presentation of the clinical phenotype of McArdle&apos;s disease in a kindred harbouring a novel compound genotype in the muscle glycogen phosphorylase gene.","volume":"391","author":"C Paradas","year":"2005","journal-title":"Neurosci Lett"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0029061","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,28]],"date-time":"2020-06-28T23:08:55Z","timestamp":1593385735000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0029061"}},"subtitle":[],"editor":[{"given":"Markus","family":"Schuelke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2011,12,16]]},"references-count":38,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2011,12,16]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0029061","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,16]]}}}